This page lists the SEC filings reported by Broadfin Capital, LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | PERNIX THERAPEUTICS HOLDINGS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | KEMPHARM, INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | SeaSpine Holdings Corp | 1,100,007 | 9.8% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Strongbridge Biopharma plc | 3,494,581 | 9.8% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | SCYNEXIS INC | 1,803,523 | 7.4% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | TITAN PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Retrophin, Inc. | 3,491,494 | 9.2% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Horizon Pharma plc | 6,759,819 | 4.2% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | RITTER PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | RedHill Biopharma Ltd. | 356,773 | 2.2% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Nexvet Biopharma plc | 1,127,200 | 9.6% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Tonix Pharmaceuticals Holding Corp. | 353,000 | 0.9% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | CAS MEDICAL SYSTEMS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | NOVADAQ TECHNOLOGIES INC | 407,188 | 0.7% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Corium International, Inc. | 1,919,721 | 8.5% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | CONTRAFECT Corp | 2,938,329 | 6.8% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | Lion Biotechnologies, Inc. | 5,388,808 | 8.3% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | HERON THERAPEUTICS, INC. /DE/ | 3,916,534 | 10.0% | EDGAR |
| SC 13G | 2017-02-10 | Broadfin Capital, LLC | DEXTERA SURGICAL INC | 898,053 | 10.0% | EDGAR |
| SC 13G | 2017-02-10 | Broadfin Capital, LLC | WINDTREE THERAPEUTICS INC /DE/ | 854,409 | 10.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.